Anbio Biotechnology (NNNN)
NASDAQ: NNNN · Real-Time Price · USD
6.48
-0.06 (-0.92%)
At close: Sep 8, 2026, 4:00 PM EDT
6.38
-0.16 (-2.45%)
After-hours: Sep 8, 2026, 7:54 PM EDT
Anbio Biotechnology Market Cap
Anbio Biotechnology has a market cap or net worth of $284.41 million as of September 8, 2026. Its market cap has decreased by -86.46% in one year.
Market Cap
284.41M
Enterprise Value
272.51M
1-Year Change
-86.46%
Ranking
Category
Stock Price
$6.48
ChartMarket Cap Chart
Since the IPO on February 19, 2025, Anbio Biotechnology's market cap has increased from $219.46M to $284.41M, an increase of 29.60%. That is a compound annual growth rate of 18.20%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 284.41M | -78.45% |
| Dec 31, 2025 | 1.32B | 501.40% |
| Feb 19, 2025 | 219.46M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Azenta | 1.37B |
| STAAR Surgical Company | 1.18B |
| AngioDynamics | 628.25M |
| Embecta | 328.63M |
| Sanara MedTech | 319.10M |
| OraSure Technologies | 240.01M |
| Pro-Dex | 235.16M |
| Utah Medical Products | 226.37M |